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Abstract 
Purpose: To identify, characterize and structurally elucidate bioactive compounds from root of Ruellia 
squarrosa. 
Methods: One kilogram of crude Ruellia squarrosa root was shade dried for 14 days, ground to a fine 
powder and subjected to a methanol extraction. The resultant extract underwent column 
chromatography for further purification. The isolated compounds were subjected to ultraviolet 
spectroscopy (UV), infra-red (IR), proton nuclear magnetic resonance (1H-NMR), 13C–NMR and  high 
resolution electron ionization mass spectrometry (HR-EI-MS) for the identification, characterization and 
structural elucidation of bioactive compounds. The most active compounds were tested for anticancer 
activities against human prostate cancer cell. 
Results: Two active compounds, squarrosol and squarrosal, were obtained with half-maximal inhibitory 
concentration (IC50) of 15.6 and 26.6 μg/mL, respectively, against human prostate cancer cell lines. 
Squarrasol showed a significantly (p < 0.05) greater inhibition of cell proliferation than the same dose of 
squarrasal. 
Conclusion: These findings suggest that extracts of Ruellia squarrosa containing the bioactive 
compounds, squarrosol and squarrosal, can potentially be developed for the treatment of human 
prostate cancer. 
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Medicinal plants have made a great impact on 
human health and extracts have been used for 
treatment of various diseases and have been 
found to have antimicrobial activity and antiviral 
activity [1-3]. Researchers have turned their 
attention towards herbal products as potential 
sources in their search for more effective drugs 
in the treatment of cancer, cardiac and infectious 
diseases [4,5]. Since ancient time, plants and 
plant extracts have been used traditionally as 
medicinal remedies and it is estimated that 80-85 
% of the world population relies on herbal plants 
and extracts for medicinal purposes [6]. 
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The genus Ruellia, generally known as Ruellias 
or Wild Petunias, belongs to the family 
Acanthaceae. It includes about 250 genera and 
2500 species.  Most of these are shrubs or 
twining vines; some are epiphytes, with most 
species occurring in tropical regions and only a 
few being distributed in temperate regions. They 
are found in Indonesia, Malaysia, Africa, Brazil, 
Central America and Pakistan. They are 
represented in Pakistan by 5 species, of which 3 
are native [7]. Extracts of different species of 
genus Ruellia have been reported to possess 
anti-inflammatory, anti-pyretic [8], antiulcer [9], 
antiproliferative [10] and antidiabetic activities 
[11]. The plant Ruellia squarrosa has been used 
traditionally for the treatment of stomach cancer. 
Dried root extracts of the plant has been used 
used to induce abortions and for inflammation in 
the eyes [12].  
 
The present investigation was conducted in order 
to extend previous observation [13], in order to 
isolate the active compounds from plant Ruellia 
squarrosaand and evaluate their anticancer 
potential against prostate cancer cell lines by 
measuring their IC50 values and % inhibition of 






The plant Ruellia squarrosa was collected from 
the University Garden of Bahauddin Zakariya 
University (B.Z.U), Multan (District in Punjab, 
Pakistan) in August, 2013 and identified by Prof. 
Dr. Altaf Ahmad Dasti, Plant Taxonomist, 
Institute of Pure and Applied Biology, B.Z.U 
Multan, Pakistan. A reference specimen (fl.c.1-2) 
was deposited in the Institute of Pure and 




Roots of Ruellia squarrosa, 500 g, were shade 
dried for two weeks and then powdered by using 
homogenizer. The fine powder was subjected to 
extraction by mixing with one liter volume of 
methanol at room temperature for 24 hours. The 
methanol extract was filtered and dried by 
rotavapor - R200 at 35oC until semisolid 
appearance of extract was observed in collection 
flask. A total amount of 35 g of extract of 





The methanolic extract, about 8g, was 
fractionated using silica gel 60 column 
chromatography and step wise elusion with a 
mixture of chloroform: methanol: water (70:30:4 
v/v/v) in increasing order of polarity.  Six fractions 
were obtained using this approach. Fraction 3 
containing, 370 mg, was further fractionated 
using silica gel 60 column chromatography but 
with stepwise elution using a ethyl acetate: 
methanol: water (98: 14: 7 v/v/v) respectively. As 
a result, 9 sub-fractions were obtained from 
which two pure compounds were isolated namely 
compound squarrosal, approximately 6 mg, and 




For TLC purposes, aluminum sheets pre-coated 
with silica gel 60 F254 (20×20 cm, 0.2 mm thick; 
E-Merck) were used to check the percentage 
purity of the compounds. The visualization of 
components took place under ultraviolet light 
(254 and 366 nm) followed by Godine reagent 
and 10% sulphuric acid as a spraying reagent. 
Column chromatography for isolation purposes 
used silica gel, 70-230 mesh, and 230-400 mesh 
along with sephadex LH-20.  An IR spectrum 
was recorded using a Bruker vector-200 
spectrophotometer (ν in cm−1). The 1H-NMR 
spectrum was measured using a Bruker Avon-
300 MHz instrument with TMS as an internal 
standard. The chemical shift values were 
reported in ppm (δ) units and the coupling 
constants (J) are recorded in Hz.  The 13C -NMR 
spectrum was also recorded using the Bruker 
Avon-300 MHz instrument. EI-MS spectrum was 
measured using a Jeol JMS-600H spectrometer 
and HREI-MS with a MET-95-XP. 
 
Solvents and materials  
 
Methanol, dichloromethane, chloroform, n-
hexane, ethyl acetate, ethanol, propanol, n-
butanol Vanillin, silica gel (70-230 mesh), TLC 
aluminum sheets (20 x 20) cm and Silica gel 60 
F254 were imported from Merck (Darmstadt 
Germany). Sephadex LH-20 25 - 100 um and 




The separation and purification of the plant 
constituents relied mainly on different 
chromatographic techniques, the choice of which 
depended upon the property and volatility of 
compound to being identified or separated. 
 
Biological application of these compounds 
on prostate cancer cell lines 
 
An MTT assay was performed as reported 
previously [13]. Briefly, human prostate cancer 
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cells (ATCC, USA) were cultured in Dulbecco's 
Modified Eagle's Medium (DMEM) containing 5 
% foetal bovine serum were kept at 5 % 
incubator at 37 0C.  
 
Growing cells were cultivated, harvested and 
diluted with a specific medium. (5 – 10) x 
104cells/well were treated for 48 h with six 
different concentrations of squarrosol and 
squarrosal in µg/mL (2.5 - 25 ug/ml).  0.5 % 
dimethyl sulfoxide (DMSO) and 5 fluorouracil (5-
FU) were used as negative and positive control 
substances, respectively. Absorbance was read 
using a microplate reader (TECAN Infinite 
Pro®M200, Switzerland) at 570 nm using 620 nm 




The results presented are mean ± SD. One-way 
ANOVA was performed to test differences 
between groups which were considered 
significant at p < 0.05. GraphPad Prism (Graph 









UV (Me OD) λmaxlogε nm: 212 (1.2); IRυmax (KBR) 
cm-1: 2926, 2856, 1739, 1593, 1452, 1184, 1132, 
860; 1H-NMR (DMSO, 500MHz): δ7.93 ( 1H, s , 
H-1),7.92 ( 1H, d, J = 7.0 , H-2,H-3),7.24 (1H, d, 
J = 6.8 , H-2,H-4),1.58(1H, t, J = 2.8, H-2, H-
7),6.47(1H, s, H-9), 2.69(2H, q, J = 6.4, H-2,H-
12),0.74(3H, t, J = 2.5, H-13),1.16(2H, dt, J = 
2.9,3.7, H-14),1.15(2H, dt, J=2.0,H-15), 1.69(1H, 
m,  H-16),6.16(1H, dd, J = 6.0, 5.0, H-17), 6.18 
(1H, dd, J=6.8,5.1, H-18), 6.45(1H, dd, J = 5.9, 
7.0, H-19),4.42(1H, dd, J= 6.1, 6.8, H-
20),5.55(1H,d,J=7.8,H-21)3.84 
(1H,dd,J=7.2,5.0,H-22) 3.61 (1H,dd, J=5.7,3.9, 
H-23) 3.60(1H,dd, J=7.3,4.7, H-24), 6.12(1H,d, 
J=6.5, H-25); 13C-NMR (CDCl3, 125MHz): δ 
128.0 (C-1), 130.0 (C-2), 125.0 (C-3), 124.0 (C-
4), 131.0 (C-5), 167.0 (C-6), 50.0 (C-7), 115.0 
(C-8), 142.0 (C-9), 137.0 (C-10), 141.6 (C-11), 
67.9 (C-12), 63.0 (C-13), 23.7 (C-14), 39.7(C-
15), 29.3 (C-16), 154.6(C-17)131.3 (C-18), 
131.0(C-19), 154.0 (C-20), 92.5 (C-21), 77.2 (C-
22)77.0 (C-23), 76.7(C-24), 97.6(C-25): EI-MS 
m/z (rel. int): 413(400), 219(240), 166(243); HR-




Figure 1: Structure of squarrosal 
 
Squarrosal was isolated from the methanol 
fraction of Ruellia squarrosa as an amorphous 
powder. The infrared spectrum of the compound 
had absorption bands at 1739 cm-1due to lactone 
group.  A band was observed at 1593 cm-1 due 
to aromaticity.  The stretching vibrations at 2856 
cm-1 showed the presence of sp3C−H and at 
2925 cm-1 showed the presence of Sp2 C−H.  
 
The ultraviolet visible spectrum of the compound 
demonstrated an absorption band at 212 nm. 
The molecular formula was inferred as C25H28O8 
through the JEOLJMS-600H presenting a 
molecular ion peak [M+H] at m/z 456 (calculated 
for C25H28O8:456) (Table 2). The mass 
fragmentation of the compound is given in Figure 
1: 
 
The 1H-NMR spectrum of squarrosal showed a 
signal for an alcoholic group at δ3.61 (1H, dd, J = 
3.9, 5.7 Hz), 3.84 (1H, dd, J = 5.0, 7.2 Hz) and 
3.60 (1H, dd, J = 4.7, 7.3 Hz). The aliphatic ring 
protons appeared at δ 2.94 (2H, d, J = 2.6 H), 
1.16 (2H, dt, J = 2.1, 3.7 Hz); the methyl group   
appeared at δ 0.74 (3H, t); and the lactone 
hydrogen at δ 5.55 (1H, d, J = 7.8, Hz). 
 
The 13C-NMR spectrum (BB and DEPT) of 
squarrosal exhibited 25 carbon signals for one 
methyl, fifteen methines, four methylenes and 
five quaternary carbon atoms. The downfield 
signal at δ 167.6, 141.6 showed the presence of 
carbonyl carbon group. The lactone ring 
appeared at δ92.5 and 97.6; the aliphatic carbon 
appeared at δ1.176 to 2.94; and the alcoholic 
peak was observed at δ 77.2, 70.0 and 76.7. 
 




dihydronaphthalen-1(2H)-one and it was found to 
be a novel natural product. It was named on the 
basis of the species as squarrosal. 
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C – 1 CH 128.0 7.93 (s) - 
C – 2 C 130.0 - - 
C – 3 CH 125.0 7.92 (d) 7.0 
C – 4 CH 124.0 7.24(d) 6.8 
C – 5 C 131.0 - - 
C – 6 C 167.0 - - 
C – 7 CH 50.0 1.58(t) 2.8 
C – 8 C 115.0 - - 
C – 9 CH 142.0 6.47(s) - 
C – 10  C 137.0 - - 
C – 11 C 141.6 - - 
C – 12 CH2 67.9 2.69(q) 6.4 
C – 13 CH3 63.0 0.74(t) 2.5 
C – 14 CH2 23.7 1.16(dt) 2.9, 
3.7 
C – 15 CH2 39.7 1.15(dt) 2.0, 
4.5 
C – 16 CH 29.3 1.69(m) - 
C – 17 CH 154.6 6.16(dd) 6.0,5.0 
C- 18 CH 131.3 6.18(dd) 6.8, 
5.1 
C-  19 CH 131.0 6.45(dd) 5.9,7.0 
C-   20 CH 154.0 4.42(dd) 6,1,6.8 
C-   21 CH 92.5 5.55(d) 7.8 
C-  22 CH 77.2 3.84(dd) 7.2,5.0 
C-  23 CH 77.0 3.61(dd) 5.7,3.9 
C- 24 CH 76.7 3.60(dd) 7.3,4.7 






















  m/z  456
m/z 387
o
m/z 305  





Non crystalline solid (05 mg); UV (Me OD) 
λmaxlogεnm: 208 (0.65), 284 (0.14); IRυmax (KBR) 
cm-1: 3463, 3060; 1H-NMR (DMSO, 500MHz): 
δ7.65 (1H, s, H-1), 7.67 (1H, s, H-3), 4.40 (1H, d, 
J= 7.0, H-8), 4.45 (1H, d, J= 6.8 H-9), 7.46 (1H, 
d, J= 7.2, H-12), 7.48 (1H, d, J = 6.8, H-13), 7.70 
(1H, s, H-15), 0.86 (3H, s, H-16), 7.65 (1H, s,  H-
19), 7.67 (1H, s, H-21), 6.9 (1H, s, H-24), 6.43 
(1H, m, J=6.8, H-26), 4.39 (2H, d, J = 7.8, H-27), 
4.37 (3H, s, H-28); 13C-NMR (CDCl3, 125MHz): 
δ131.8 (C-1), 131.7 (C-2), 129.2 (C-3), 132.4 (C-
4), 109.5 (C-5), 140.0 (C-6), 167.5 (C-7), 128.7 
(C-8), 128.6 (C-9), 116.8 (C-10), 134.5 (C-11), 
116.3 (C-12), 121.8 (C-13), 128.7 (C-14), 115.8 
(C-15), 22.2 (C-16), 164.4 (C-17), 102.3 (C-18), 
131.7 (C-19), 117.6 (C-20), 118.6 (C-21), 114.2 
(C-22), 131.8 (C-23), 72.5 (C-24), 132.8 (C-25), 
116.8(C-26), 135.6(C-27), 60.8(C-28); EI-MS 
m/z: 484(10), 443(20), 399 (34), 354(30), 132 
(42), 89(62), 65(76) HR-EI-MS m/z:  484 [M+H]+ 




Figure 3: Structure of squarrosol 
 
Squarrosol was isolated as a noncrystalline solid 
from the methanolic extract of Ruellia squarrosa.  
In the Infrared spectrum of the Squarrosol 
compound, the absorption bands at 1726 cm-1 
was consistent with the presence of a carbonyl 
functional group. The stretching vibrations at 
34.63 cm-1 suggested the presence of Sp2 C−H. 
The ultraviolet visible spectrum displayed 
absorption peaks at 208 and 284 nm. The 
molecular formula was inferred as C28H24N2O6 
using the JEOLJMS-600H which displayed a 
molecular ion peak [M+H] at m/z 484 (calculated 
for C28H24N2O6:484) (Table 3). 
 
The 1H-NMR spectrum of the Squarrosol 
compound gave a signal for aromatic ring 
protons δ 7.67 (1H, s), 7.41 (1H, d, J = 6.5 Hz), 
7.69 (1H, d, J = 6.8Hz) 7.46 (1H, d, J = 7.2 Hz), 
7.48 (1H, d, J = 6.8 Hz), 7.65 (1H, s) and 7.67 
(1H, s). The alkene proton showed doublet and 
multiplets at δ 4.40 (1H, d, J = 7.0 Hz) 4.45 (1H, 
d, J = 6.8 Hz) and 4.39 (1H, d, J = 7.8 Hz). 
 
The 13C- NMR spectrum (BB and DEPT) of the 
Squarrosol compound was consistent with a total 
of 28 carbon signals for two methyl, eleven 
methines, one methylene and 14 quaternary 
carbon atoms. The downfield signal at δ 167.5, 
163.1, 161.7 revealed the presence of a C = O 
group. The downfield signal appeared at δ 140.0, 
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135.6, 131.8 indicating the presence of an 
aromatic functional group. 
 
The compound structure was established as (E)-
N-(3-(3-(2, 4-dihydroxy-6-methylphenyl)-3-
oxoprop-1-enyl)-4-hydroxyphenyl)-6-methoxy-5-
vinyl-1H-indole-3-carboxamide. On the basis of 
the above data, the compound was identified as 
a novel natural product and named on the bases 
of the species as squarrosol. 
 










C – 1 CH 131.8 7.65(s) - 
C – 2 C 131.7 - - 
C – 3 CH 129.2 7.67 (s) - 
C – 4 C 132.4 - - 
C – 5 C 109.5 - - 
C – 6 C 140.0 - - 
C – 7 C 167.5  - 
C – 8 CH 128.7 4.40(d) 7.0 
C – 9 CH 128.6 4.45 (d) 6.8 
 C – 10  C 116.8 - - 
C – 11 C 134.5 - - 
C – 12 CH 116.3 7.46 (d) 7.2 
C – 13 CH 121.8 7.48(d) 6.8 
C – 14 C 128.7 - - 
C – 15 CH 115.8 7.70(s) - 
C – 16 CH3 22.2 0.86 (s) - 
C – 17  C 164.4 - - 
C – 18 C 102.3 - - 
C – 19 CH 131.7 7.65(s) - 
C – 20 C 117.6 - - 
C – 21 CH 118.6 7.67 (s) - 
C – 22 C 114.2 - - 
C – 23 C 131.8 - - 
C – 24 CH 72.5 6.91 (s) - 
C – 25  C 132.8 - - 
C – 26  CH 116.8 6.43 
(m) 
- 
C – 27  CH2 135.6 4.39(d) 7.8 
C – 28  CH3 60.8 4.37(s) - 
 
Effect of squarrosal and squarrosol of cell 
proliferation 
 
The results were presented as percent viability 
compared to the negative control (mean ± SD, 
n=3). IC50 values were calculated using the anti-
proliferation activity of different concentrations of 
squarrosol and squarrosal as 15.6 and 26.6 
μg/mL respectively. Dose of dependent inhibition 




The present study was based on the isolation of 
phytochemical constituents from the herbal plant 
Ruellia squarrosa and evaluation of active 




Figure 4: Dose-dependent activity of squarrosal and 
squarrosol on prostate cell proliferation. *P < 0.05 vs. 
ose of squarrosal; #p <0.05 vs. dose of 5-FU 
 
human prostate cancer cell lines. The present 
investigation isolated two novel compounds from 
methanol extract of Ruellia squarrosa which 
belong to the flavonoid class and were named 
squarrosal and squarrosol.  Their anticancer 
potential against human prostate cancer cell 
lines was explored as this feature has been 
established with other flavonoids [14]. This study 
reported herein represents a continuation of our 
previous finding [13] in which it was found that 
extracts of different parts of the Ruellia squarrosa 
plant contain compounds which possess 
anticancer potential against human prostate 
cancer lines. However, the previous study was 
unable to isolate the active compounds. The 
current investigation set out to isolate the active 
constituents of Ruellia squarrosa.  It was found 
that squarrosol and squarrosal both exhibited 
dose dependent inhibition of proliferation of the 
prostate cancer cells.  Squarrosol exhibited a 
significantly greater (p < 0.05) % inhibition of 
proliferation against prostate cancer cell lines 
when compared to that of squarrosal. However, 
this activity was less than the degree of inhibition 
of prostate cancer cell proliferation using the 
standard drug, 5-FU. These flavonoids are 
amongst the few medicinal plants which have 
been reported to have anticancer potential and 
this activity is in line with the flavones which have 
been reported to have broad activity against 
tumors, leukemia, lymphomas and solid tumors 
[15]. This study is also in line with recent study 
[13] which demonstrated that flavonoids may be 
potential therapeutic compounds for the 




These findings show that squarrosal and 
squarrosol are the main active compounds 
contained in the extracts of Ruellia squarrosa 
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prostate cancer cells. Thus, these compounds 
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